Project Grant R01AA032039
- Federal Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded Trustees of Boston University a $1.74M Project Grant on September 17, 2025, under the Alcohol Research Programs (CFDA 93.273) to conduct comprehensive research evaluating the associations between state alcohol taxation policies, the policy environment, and alcohol use disorder (AUD) health service outcomes. The project, extending through August 31, 2028, will employ advanced statistical methods...
- Federal Grant Award Summary Funding Agency: National Institute on Alcohol Abuse and Alcoholism (NIAAA) Federal Grant Program: Alcohol Research Programs (CFDA 93.273) Award Amount: $559,180 Award Date: September 1, 2025 Project Period: September 1, 2025 – June 30, 2030 Awardee: RTI International (Research Triangle Institute), Research Triangle Park, North Carolina RTI International will conduct multi-omic research to identify neurobiological factors underlying alcohol use disorder (AUD) with...
- Federal Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $459,343 Project Grant to the University of Pittsburgh under the Alcohol Research Programs (CFDA 93.273) to conduct fundamental neuroscience research examining the mechanisms through which alcohol affects prefrontal cortex circuits, with performance extending from September 20, 2025 through July 31, 2030. The research focuses on understanding how vasoactive intestinal peptide-expressing...
- Federal Grant Award Summary Wake Forest University Health Sciences received a $2.55 million Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), effective September 5, 2025, with a completion date of August 31, 2029. The award supports a four-year research initiative investigating the insula-bed nucleus of the stria terminalis (BNST) neural circuit's role in alcohol use disorder (AUD) development. The...
- Federal Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded Mayo Clinic a $734,283 Project Grant effective September 5, 2025, through June 30, 2030, under the Alcohol Research Programs (CFDA 93.273) to investigate the neurobiological mechanisms underlying alcohol use disorder (AUD) and treatment response. The primary research deliverable involves measuring circulating neuroactive steroid levels—specifically allopregnanolone (ALLO), its precursors, and...
- Federal Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded the University of Florida a $560,108 Project Grant on September 15, 2025, under the Alcohol Research Programs (CFDA 93.273) to conduct a five-year investigation into the neurocognitive mechanisms of resilience to alcohol use disorder (AUD). The research will examine how attentional ability protects against AUD development in at-risk young adults with a family history of alcohol use disorder. This...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded Boston University Medical Campus a Project Grant totaling $221,401.00, effective September 1, 2025, through August 31, 2027, under the Alcohol Research Programs (CFDA 93.273). This award supports research investigating the role of somatostatin (SST) and its receptor mechanisms in the central nucleus of the amygdala (CEA) as an anti-stress system that may suppress heavy alcohol drinking behavior. The research addresses a...
- Federal Project Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded The Medical University of South Carolina $459,707 on September 5, 2025, under the Alcohol Research Programs (CFDA 93.273) to support a five-year research project extending through May 31, 2030. This Project Grant funds basic neuroscience research investigating the physiological mechanisms underlying alcohol use disorder (AUD), specifically examining how chronic intermittent ethanol (CIE)...
- Grant Award Summary The Medical University of South Carolina received a $151,040 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) to conduct fundamental neuroscience research examining the role of orexinergic neural circuits in alcohol dependence and excessive consumption. Awarded on March 9, 2026, with completion targeted for November 30, 2027, this project delivers preclinical research services...
- Federal Grant Award Summary The University of Pittsburgh received a $628,080 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), effective May 1, 2026 through April 30, 2031. This award supports neurobiological research investigating the role of the nociceptin opioid peptide (NOP) receptor system in alcohol use disorder (AUD) relapse, specifically in heavy drinking populations. The research utilizes positron...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded Boston University Medical Campus a $580,556 Project Grant, effective May 1, 2026 through January 31, 2031, under the Alcohol Research Programs (CFDA 93.273). This award supports translational and mechanistic research investigating the role of pituitary adenylate cyclase activating polypeptide (PACAP) in heavy alcohol drinking and associated anxiety-like behaviors. The research employs well-established animal models of heavy alcohol consumption combined with pharmacological, molecular, and viral approaches to elucidate PACAP's function within the bed nucleus of the stria terminalis (BNST) and its interaction with corticotropin-releasing factor (CRF) neurons, with particular focus on PACAP projections from the lateral parabrachial nucleus. The primary deliverable is a comprehensive mechanistic investigation that advances understanding of the neuroadaptations underlying alcohol use disorder (AUD), specifically the role of the PACAP neuropeptide system in the extended amygdala neurocircuitry. The research is designed to identify potential therapeutic targets for AUD treatment, addressing a significant public health need given the limited pharmacological treatment options currently available. By elucidating the molecular mechanisms linking stress neurotransmitter systems to compulsive drinking behavior, this project contributes foundational knowledge applicable to the development of novel therapeutic agents for alcohol use disorder prevention and treatment.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $580.6k | 5/4/26 |